Skip to main content
Profound Medical Corp. logo

Profound Medical Corp. — Investor Relations & Filings

Ticker · PROF TSX Manufacturing
Open in API
Filings indexed 659 across all filing types
Latest filing 2023-04-19 Investor Presentation
Country CA Canada
Listing TSX PROF

About Profound Medical Corp.

https://profoundmedical.com/

Profound Medical Corp. is a commercial-stage medical technology company specializing in incision-free ablative therapies. Its core product is TULSA-PRO®, a therapeutic platform designed for the treatment of localized prostate cancer, radiorecurrent prostate cancer, and benign prostatic hyperplasia (BPH). TULSA-PRO utilizes a robotically controlled, transurethral ultrasound ablation procedure guided by real-time Magnetic Resonance (MR) imaging. This system employs closed-loop temperature feedback to ensure precise and customizable tissue ablation, prioritizing patient safety and minimizing complications. The technology merges MR imaging, thermal ultrasound, and robotics to offer a durable and accurate treatment delivery method.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Investor Presentation Classification · 85% confidence The document is a press release announcing that Profound Medical will participate in an upcoming healthcare investor conference and provide a business update. It includes details about the conference date, time, and how to access the presentation. There are no financial statements, detailed financial results, or regulatory filings included. The document is short (2653 characters) and serves as an announcement of an investor presentation event rather than the presentation itself or a financial report. Therefore, it fits best under the category of Investor Presentation (IP) as it relates to a detailed presentation for investors focusing on financials, strategy, and market position, even though the actual presentation will occur later and be available on the website.
2023-04-19 English
Notice of the meeting and record date - English.pdf
Regulatory Filings
2023-03-10 English
52-109F1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings
2023-03-08 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings
2023-03-08 English
News release - English.pdf
Regulatory Filings
2023-03-07 English
News release - English.pdf
Investor Presentation Classification · 90% confidence The document is a press release announcing that Profound Medical will present at the 43rd Annual Cowen Health Care Conference. It contains no financial statements, no detailed financial data, no regulatory filings, or voting results. It is an announcement of an upcoming investor presentation event, not the presentation itself or a report. The document length is short (2605 characters), and it primarily serves as an investor relations announcement about a future presentation. Therefore, the most appropriate classification is Investor Presentation (IP).
2023-03-01 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.